Crossmark

Targeted Axillary Dissection Versus Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: Why Staging Accuracy Matters

Published Online: 2026-02-23

Published Print: 2026-05

Authors

Venkataraman, Janhavi https://orcid.org/0000-0002-4924-6680
Mokbel, Kefah
License Information

Text and Data Mining valid from 2026-02-23

Version of Record valid from 2026-02-23
More Information

Article History

Received: 23 January 2026

Accepted: 26 January 2026

First Online: 23 February 2026

Disclosure

: Kefah Mokbel has received honoraria from Merit Medical, the manufacturer of the SAVI SCOUT breast localization system, for advisory services.

Document is current